Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Nerviano Medical Sciences presents new JAK2 inhibitors

Nov. 19, 2012

Zaltrap receives positive CHMP opinion for metastatic colorectal cancer

Nov. 19, 2012

Novel JAK3 inhibitors presented by Cellzome (GlaxoSmithKline)

Nov. 19, 2012

Brazilian researchers disclose new radioactive iodine compounds

Nov. 19, 2012

TAS-117 demonstrates potent antitumor activity alone and in combination

Nov. 19, 2012

Gynecologic Oncology Group begins phase II trial of dalantercept

Nov. 19, 2012

New protein kinase inhibitors disclosed by China State Institute of Pharmaceutical Industry

Nov. 19, 2012

RP-7047 evaluated for the treatment of acute lymphoblastic lymphoma

Nov. 19, 2012

Epizyme and Eisai patent novel agents for cancer

Nov. 16, 2012

U.S. Department of Health & Human Services reports novel PLK1 inhibitor compounds

Nov. 16, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...